BPrinStratTTE
Causal Effects in Principal Strata Defined by Antidrug Antibodies
Bayesian models to estimate causal effects of biological treatments on time-to-event endpoints in clinical trials with principal strata defined by the occurrence of antidrug antibodies. The methodology is based on Frangakis and Rubin (2002) doi:10.1111/j.0006-341x.2002.00021.x and Imbens and Rubin (1997) doi:10.1214/aos/1034276631, and here adapted to a specific time-to-event setting.
- Version0.0.7
- R version≥ 3.4.0
- LicenseGPL (≥ 3)
- Needs compilation?Yes
- Languageen-US
- Last release04/13/2024
Documentation
Team
Christian Stock
Emma Torrini
Show author detailsRolesAuthorBoehringer Ingelheim Pharma GmbH & Co. KG
Show author detailsRolesCopyright holder, fnd
Insights
Last 30 days
Last 365 days
The following line graph shows the downloads per day. You can hover over the graph to see the exact number of downloads per day.
Data provided by CRAN
Binaries
Dependencies
- Imports10 packages
- Suggests1 package
- Linking To6 packages